Interesting facts
Interesting Facts about 6-Methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
The compound 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole is a fascinating compound within the realm of medicinal chemistry. Its unique structure and properties contribute significantly to its utility in various applications.
Chemical Attributes and Applications
- Biological Activity: This compound has shown promising pharmacological properties, particularly as a potential therapeutic agent in treating various diseases. Its design is inspired by the need for more effective drugs in specific therapeutic areas.
- Structural Complexity: The presence of both a benzimidazole core and a pyridine ring highlights the compound's complexity, which can lead to a wide range of biological interactions.
- Application in Drug Development: The functional groups present, such as the methoxy and sulfinyl groups, are known to influence the compound's interaction with biological targets, demonstrating their importance in drug design strategies.
Significance in Research
This compound exemplifies the *importance of structure-activity relationships (SAR)* in medicinal chemistry. As researchers continue to explore its potential, the following points stand out:
- The **methoxy groups** enhance lipophilicity and may affect the compound's oral bioavailability.
- The **sulfinyl moiety** introduces chirality, adding another layer of complexity to its biological activity, which is an essential consideration in drug development.
- Ongoing studies are focusing on the **mechanism of action** of this compound, aiming to elucidate its therapeutic potential.
In summary, 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole serves as an excellent justification for the synthesis of novel compounds aimed at revolutionizing modern medicine. Its unique attributes promise exciting advancements in our understanding and ability to combat diseases.
Synonyms
omeprazole
73590-58-6
Losec
Prilosec
Antra
Audazol
Omeprazon
Mopral
Omapren
Parizac
Ceprandal
Dizprazol
Emeproton
Epirazole
Gastrimut
Gastroloc
Inhibitron
Logastric
Peptilcer
Sanamidol
Secrepina
Ulcometion
Belmazol
Dudencer
Gibancer
Indurgan
Inhipump
Miracid
Omepral
Omeprol
Ompanyt
Pepticum
Prazidec
Ramezol
Ulceral
Ulcesep
Ulcozol
Zegerid
Desec
Elgam
Lomac
Mepral
Omezol
Omisec
Omizac
Ozoken
Prysma
Ulsen
Ultop
Zefxon
Zimor
Zoltum
Miol
Ocid
Omed
OMEP
Omid
Demeprazol
Nopramin
Omeprazol
Omezolan
Paprazol
Pepticus
Prazentol
Prazolit
Procelac
Regulacid
Danlox
Erbolin
Lensor
Morecon
Nilsec
Olexin
Omegast
Omesek
Ortanol
Proclor
Result
Ulcsep
Victrix
Zepral
Exter
Gasec
Ulzol
Tedec Ulceral
Omebeta 20
AULCER
Osiren
Antra MUPS
Omez
Omeprazolum
Omerprazole
Gastrogard
Omepradex
H 168/68
Omesec
119141-88-7
Omeprazol [INN-Spanish]
Omeprazolum [INN-Latin]
Nuclosina
Omeprazole delayed-release
(+-)-Omeprazole
MFCD00083192
CCRIS 7099
HSDB 3575
H-168/68
OMZ
Prestwick_808
5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
NSC-751450
NSC-759192
UNII-KG60484QX9
6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole
1H-Benzimidazole, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-
DTXSID6021080
CHEBI:77260
Omeprazole 13CD3
Esomeprazole sodium salt
KG60484QX9
6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
Aisi'aomeilazuona Esomeprazole Sodium
326602-80-6
CHEMBL1503
2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole
5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole
5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
MLS000069373
DTXCID501080
Omeprazole-d6
ZEGERID COMPONENT OMEPRAZOLE
73590-58-6 (free form)
YOSPRALA COMPONENT OMEPRAZOLE
5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-3H-benzoimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methane]sulfinyl}-1H-1,3-benzodiazole
NSC 751450
NSC 759192
Omeprazole [USAN:USP:INN:BAN:JAN]
NCGC00016925-06
Esomperazole
SMR000058847
Emilok
CAS-73590-58-6
Omeprazol (INN-Spanish)
Omeprazolum (INN-Latin)
OMEPRAZOLE (MART.)
OMEPRAZOLE [MART.]
(s)-omeprazole sodium
2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole
OMEPRAZOLE (USP-RS)
OMEPRAZOLE [USP-RS]
( -)-Omeprazole
OMEPRAZOLE (USP IMPURITY)
OMEPRAZOLE [USP IMPURITY]
Omeprazone
Omebeta
Omeprazen
OMEPRAZOLE (USP MONOGRAPH)
OMEPRAZOLE [USP MONOGRAPH]
Olit
Omeprazole (USAN:USP:INN:BAN:JAN)
Omeprazole Pellets
1H-Benzimidazole,5-methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-
5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole
5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]benzimidazole
Prilosec (TN)
5-METHOXY-2-(((4-METHOXY-3,5,-DIMETHYL-2-PYRIDINYL)-METHYL)SULPHINYL)-1H-BENZIMIDAZOLE
(S)-6-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
SR-01000003003
668985-31-7
omeprazolo
UlcerGard
OmeprazoleDR
welby omeprazole
Omeprazole Dr
SAN-15
161796-78-7
careone omeprazole
Leader Omeprazole
Omeprazole, solid
5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
AGI-010
Omeprazole,(S)
Sunmark Omeprazole
Topcare Omeprazole
24 hr omeprazole
Omeprazole-[d3]
Equaline Omeprazole
good now omeprazole
(RS)-6-METHOXY-2-((4-METHOXY-3,5-DIMETHYLPYRIDIN-2-YL) METHYLSULFINYL)-1H-BENZO(D)IMIDAZOLE
(RS)-6-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl) methylsulfinyl)-1H-benzo[d]imidazole
5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole;H 168 68
Care One Omeprazole
DG health omperazole
Dg Health Omeprazole
caring mill omeprazole
Good Sense Omeprazole
Sound Body Omeprazole
Up and Up Omeprazole
DM-3458
5-Methoxy-2-
Omeprazole (Prilosec)
Omeprazole (Standard)
Core Values Omeprazole
Health Mart Omeprazole
Members Mark Omeprazole
OMEPRAZOLE [MI]
Harris Teeter Omeprazole
OmeprazoleDelayed Release
OMEPRAZOLE [INN]
OMEPRAZOLE [JAN]
Maybridge4_002645
Opera_ID_1863
Prestwick0_000493
Prestwick1_000493
Prestwick2_000493
Prestwick3_000493
Quality Choice Omeprazole
Signature Care Omeprazole
(.+/-.)-Omeprazole
OMEPRAZOLE [HSDB]
OMEPRAZOLE [USAN]
O0359
Exchange Select Omeprazole
Family Wellness Omeprazole
OMEPRAZOLE [VANDF]
UPCMLD-DP075
cid_4594
foster and thrive omeprazole
SCHEMBL1191
OMEPRAZOLE [WHO-DD]
H168/68
Kirkland Signature Omeprazole
BSPBio_000385
Berkley and Jensen Omeprazole
MLS001076112
MLS001424148
MLS006010400
MLS006011759
BIDD:GT0189
SPBio_002306
BPBio1_000425
CHEBI:7772
GTPL4279
Omeprazole (JP18/USP/INN)
Omeprazole - Bio-X trade mark
Esomeprazole sodium salt hydrate
OMEPRAZOLE [GREEN BOOK]
OMEPRAZOLE [ORANGE BOOK]
PA-32540 component omeprazole
SCHEMBL11995456
UPCMLD-DP075:001
CHEBI:91766
Equate omeprazole delayed release
HY-B0113R
A02BC01
Good Neighbor Pharmacy Omeprazole
TopCare Omeprazole delayed release
equaline omeprazole delayed release
HMS1528I05
HMS1569D07
HMS2052G17
HMS2090E16
HMS2090F11
HMS2096D07
HMS2232B21
HMS3269D17
HMS3394G17
HMS3413J07
HMS3651A11
HMS3677J07
HMS3713D07
Pharmakon1600-01505693
(S)-Omeprazole sodium salt hydrate
BCP05852
BCP13592
BCP21299
HY-B0113
JMB29391
TBB98531
2,3,5-Trimethylpyridine/Omeprazole
Tox21_110686
Tox21_200509
AC-401
BBL028172
BDBM50103597
BDBM50241343
DL-462
good sense omeprazole delayed release
MFCD23135254
NSC751450
NSC759192
s1389
STK623746
119141-88-7 (base)
AKOS005066653
AKOS015895343
OMEPRAZOLE COMPONENT OF ZEGERID
Tox21_110686_1
AC-4676
CCG-101130
CCG-213517
CS-1868
DB00338
FM26561
HS-0055
NC00380
OMEPRAZOLE COMPONENT OF YOSPRALA
IDI1_032523
NCGC00016925-01
NCGC00016925-02
NCGC00016925-03
NCGC00016925-04
NCGC00016925-05
NCGC00016925-07
NCGC00016925-08
NCGC00016925-10
NCGC00016925-11
NCGC00021522-03
NCGC00021522-04
NCGC00021522-05
NCGC00258063-01
Omeprazole, analytical reference material
BO164173
SY009746
SY077145
SBI-0206896.P001
Equate omeprazole delayed releaseacid reducer
H 199
NS00003806
SW196942-4
6-Methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt
C07324
D00455
EN300-117238
668985-31-7 (Mg)
A837865
Q422210
SR-01000003003-4
SR-01000003003-7
SR-01000003003-8
5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)
BRD-A55962179-001-04-9
BRD-A55962179-001-08-0
BRD-A55962179-001-20-5
BRD-A55962179-001-21-3
BRD-A55962179-001-22-1
BRD-A55962179-001-23-9
BRD-A55962179-001-24-7
BRD-A88691025-001-07-4
F0001-2386
Z1501475006
Omeprazole, British Pharmacopoeia (BP) Reference Standard
Omeprazole, European Pharmacopoeia (EP) Reference Standard
Omeprazole, United States Pharmacopeia (USP) Reference Standard
2-(3-methoxy-2,4-dimethylbenzylsulfinyl)-6-methoxy-1H-benzo[d]imidazole
Omeprazole, Pharmaceutical Secondary Standard; Certified Reference Material
(+)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-sulfinyl]-1h-benzimidazole
(-)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-sulfinyl]-1h-benzimidazole
(RS)-5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzimidazole
(RS)-5-Methoxy-2-(4-methoxy-3,5-dimethyl-2-pyridylmethylsulphinyl)benzimidazole
(S)-5-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-3H-benzoimidazole
1H-benzimidazole, 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-
5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyrdinyl)-methyl]sulfinyl]-1H-benzimidazole
5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1 H-benzimidazole
5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole
5-methoxy-2-(2-(4-methoxy-3,5-dimethylpyridin-2-yl)ethylsulfinyl)-1H-benzo[d]imidazole
5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole
5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl- 1H-benzimidazole
5-Methoxy-2-[(RS)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-1H-benzimidazole
5-methoxy-2-[[(3,5-dimethyl-4-methoxy-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole
5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulphinyl]-1H-benzimidazole
5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-benzimidazole
5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphinyl]1H-benzimidazole
6-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole
6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole
6-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-1H-benzimidazole
6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole
6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1h-benzimidazole
6-methoxy-2-[[(4-methoxy-3,5dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole
6-methoxy-2-[[(4-methoxy3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole
6-methoxy-2-[[(4methoxy-3,5-dimethyl2-pyridinyl)methyl]sulfinyl]-1h-benzimidazole
Omeprazole for peak identification, European Pharmacopoeia (EP) Reference Standard
rac-5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzimidazole
(omeprazole)5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole
1H-BENZIMIDAZOLE,6-METHOXY-2-[(R)-[(4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL]SULFINYL]-
5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole (omeprazole)
5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole(Omeprazole)
Solubility of 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
The compound 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole, with the chemical formula C17H19N3O3S, exhibits some notable solubility characteristics worth discussing. Generally, the solubility of a compound can be influenced by various factors such as:
Specifically for this compound, its methoxy groups and the nitrogen atoms present in the structure suggest a moderate level of hydrophilicity, which could contribute to its solubility in polar solvents. However, the presence of a large hydrophobic aromatic system might limit solubility in highly polar environments. Therefore, a more likely scenario would involve:
It is always wise to conduct solubility tests under varied conditions to gain a comprehensive understanding of how this compound behaves in different solvents. As a rule of thumb, "like dissolves like" can serve as a guiding principle in predicting the solubility of diverse compounds.